A SINGLE MISSENSE MUTATION IN 77% OF PROSTATE CANCER BONE METASTASES: NOVEL OPPORTUNITY FOR GENETIC BIOMARKER AND NOVEL THERAPEUTIC MITOCHONDRIAL TAR

$509,451FY2016Department of DefenseDOD

Emory University, Atlanta GA

Investigators